An Observational, Retrospective Analysis of Retreatment with Bortezomib for Multiple Myeloma
Features and Risk Factors of Peripheral Neuropathy During Treatment with Bortezomib for Advanced Multiple Myeloma
Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma
[18F]Fluorodeoxyglucose Positron Emission Tomography Scanning for Staging, Response Assessment, and Disease Surveillance in Patients with Mantle Cell Lymphoma
Cost-Effectiveness of Extended Adjuvant Rituximab for US Patients Aged 65-70 Years with Follicular Lymphoma in Second Remission
Promoter Hypermethylation of the MEG3 ( DLK1/MEG3 ) Imprinted Gene in Multiple Myeloma
Desensitization to Thalidomide in a Patient with Multiple Myeloma
Diffuse Large B-Cell Lymphoma Presenting as Multiple Lymphomatous Polyposis of the Gastrointestinal Tract
Successful Autologous Peripheral Blood Stem Cell Transplantation for a Patient with Primary Adrenal Lymphoma with Hemophagocytic Syndrome
Association Between Renal Cell Carcinoma and Plasma Cell Dyscrasias: A Case Series of Six Patients
A Case of Plasmacytoma of the Breast Mimicking an Inflammatory Carcinoma